MENU
+Compare
BETRF
Stock ticker: OTC
AS OF
Nov 12 closing price
Price
$0.04
Change
-$0.00 (-0.00%)
Capitalization
6.5M

BETRF BETTERLIFE PHARMA INC. Forecast, Technical & Fundamental Analysis

BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union... Show more

BETRF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BETRF with price predictions
Nov 12, 2025

BETRF's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for BETRF turned positive on October 22, 2025. Looking at past instances where BETRF's MACD turned positive, the stock continued to rise in of 73 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where BETRF advanced for three days, in of 136 cases, the price rose further within the following month. The odds of a continued upward trend are .

BETRF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BETRF as a result. In of 144 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BETRF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BETRF entered a downward trend on October 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BETRF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (322.723).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BETRF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BETRF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1275 West 6th Avenue
Phone
+1 604 551-5178
Employees
4
Web
https://www.abetterlifepharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EBC17.710.21
+1.20%
Eastern Bankshares
DUOT8.990.10
+1.12%
Duos Technologies Group
SLRC15.48N/A
N/A
SLR Investment Corp
TMDE0.69-0.03
-3.57%
TMD Energy Ltd.
GFI41.29-1.57
-3.66%
Gold Fields Ltd

BETRF and Stocks

Correlation & Price change

A.I.dvisor tells us that BETRF and AVCTF have been poorly correlated (+15% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BETRF and AVCTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BETRF
1D Price
Change %
BETRF100%
-0.46%
AVCTF - BETRF
15%
Poorly correlated
N/A
BSEM - BETRF
3%
Poorly correlated
+1.82%
BPMUF - BETRF
1%
Poorly correlated
N/A
BIXT - BETRF
1%
Poorly correlated
-3.51%
BIESF - BETRF
-2%
Poorly correlated
N/A
More